It has been demonstrated that necroptosis is activated in the brains of AD patients, as evidenced by the increased expression levels of RIPK1 and MLKL, two key proteins of necroptosis, in the brain of AD patients [91]. Here, RIPK1 is linked to Alzheimer disease.